Immediate Impact
3 from Science/Nature 69 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy
2024 Standout
Works of A. Sandler being referenced
MA 05.09 Pre-Existing Immunity Measured by Teff Gene Expression in Tumor Tissue is Associated with Atezolizumad Efficacy in NSCLC
2017
16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC)
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Sandler | 512 | 380 | 118 | 35 | 589 | |
| Emiddio Barletta | 388 | 329 | 90 | 28 | 569 | |
| Norikazu Matsuo | 416 | 354 | 89 | 39 | 635 | |
| Noelia Vilariño | 396 | 303 | 96 | 27 | 559 | |
| Beung‐Chul Ahn | 480 | 345 | 100 | 36 | 588 | |
| Wen Lin | 419 | 228 | 135 | 24 | 537 | |
| L Portalone | 410 | 420 | 155 | 26 | 656 | |
| Tamjeed Ahmed | 296 | 276 | 121 | 31 | 526 | |
| Ramón Palmero | 371 | 317 | 155 | 48 | 618 | |
| Tsukihisa Yoshida | 374 | 450 | 121 | 33 | 643 | |
| Raphael Brandão Moreira | 472 | 349 | 103 | 26 | 678 |
All Works
Loading papers...